Explore Stanford technologies available for licensing:

Stanford researchers have developed a technology that predicts deep brain activity from standard scalp EEG recordings.

Researchers at Stanford have developed a novel endoscopic system for electrical stimulation and signal recording of olfactory tissue through a minimally invasive nasal approach.

Stanford researchers have developed a new software platform that transforms clinical ambulatory cardiac monitoring.

Stanford Medicine researchers in The Stuart Goodman Lab have developed a bone anchor system for surgical tracking that is easier to use and decreases complications caused by conventional knee or hip replacement bone pin anchors.

Stanford Artificial Retina Project researchers have developed an ASIC Retina Chip that interfaces with retinal ganglion cells to restore vision in patients with retinal degeneration.

Stanford researchers have developed an innovative wearable device that enhances mindfulness training by augmenting the user's real-time auditory environment.

Stanford researchers have developed EphrinA3 technology to strengthen epithelial barriers by increasing expression of cell-cell adhesion molecules, particularly desmoglein-1 (DSG1) and desmocollin-1 (DSC1).

Diagnosis and sub-typing of inflammatory bowel disease (IBD) subsets, such as Crohn's disease (CD) and ulcerative colitis (UC), often require the use of repeated, invasive, and expensive endoscopy procedures, which are not without risk.

The Stanford team developed a groundbreaking approach to measure single molecules by precisely measuring the forces induced by the absorption of electromagnetic radiation.

Stanford researchers have developed a technology for the automated separation of arteries and veins in single-phase brain CT angiography (CTA) using graph neural networks, enabling precise collateral scoring and improved stroke prognosis.

Researchers in Professor Justin Sonnenburg's laboratory have developed genetic tools for manipulating Bacteroides, a prominent genus of gut bacteria, for imaging, diagnostics, and therapeutic drug delivery.

Stanford scientists have discovered a previously unrecognized blood immune cell marker for osteoarthritis (OA) early detection.

Scientists in the De Lecea and Pauly labs optimized ultrasound waveforms that non-invasively modulate brain circuits in freely moving mice.

Stanford researchers have developed a system that assesses altered mental states in both human and animal subjects using neural biomarkers, allowing for repeatable cross-species studies of potential treatments for psychiatric and neurological disorders.

Stanford researchers have developed a novel blood-based diagnostic platform that leverages circulating bacteriophage DNA (phage cfDNA) to enable sensitive and highly specific detection of both overt and subclinical bacterial infections, while effectively discriminating them fr